Skip to main content
Clinical Trials/IRCT20221010056141N1
IRCT20221010056141N1
Recruiting
Phase 3

Evaluation of the effect of a complete course of betamethasone on neonatal and mothers with Premature rupture of membranes at 34 to 36 weeks of pregnancy

Shahid Beheshti University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Premature Rupture of Membrane.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
200
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Mothers with Premature rupture of membranes
  • At 34 to 36 weeks of pregnancy
  • Singleton pregnancy

Exclusion Criteria

  • Symptoms of chorioamnionitis in mother:fever, tachycardia
  • Infants small for gestational age
  • Infants large for gestational age
  • Any indication of emergency termination confirmed by fetal assessment
  • Maternal diabetes
  • Passing more than 48 hours from rupture of membrane

Outcomes

Primary Outcomes

Not specified

Similar Trials